1. Home
  2. CREX vs VNRX Comparison

CREX vs VNRX Comparison

Compare CREX & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Creative Realities Inc.

CREX

Creative Realities Inc.

N/A

Current Price

$3.68

Market Cap

36.8M

Sector

Technology

ML Signal

N/A

Logo VolitionRX Limited

VNRX

VolitionRX Limited

N/A

Current Price

$0.21

Market Cap

31.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CREX
VNRX
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.8M
31.9M
IPO Year
2015
2012

Fundamental Metrics

Financial Performance
Metric
CREX
VNRX
Price
$3.68
$0.21
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$2.50
AVG Volume (30 Days)
26.9K
12.0M
Earning Date
05-13-2026
03-27-2026
Dividend Yield
N/A
N/A
EPS Growth
2.86
38.00
EPS
N/A
N/A
Revenue
$18,437,000.00
$1,233,511.00
Revenue This Year
$11.51
$68.22
Revenue Next Year
$83.66
$382.75
P/E Ratio
N/A
N/A
Revenue Growth
5.61
59.10
52 Week Low
$1.28
$0.17
52 Week High
$4.00
$0.94

Technical Indicators

Market Signals
Indicator
CREX
VNRX
Relative Strength Index (RSI) 59.04 48.21
Support Level $3.01 $0.17
Resistance Level $3.70 $0.27
Average True Range (ATR) 0.16 0.02
MACD -0.01 0.00
Stochastic Oscillator 61.25 25.93

Price Performance

Historical Comparison
CREX
VNRX

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: